Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

I doubt Missling got any offer from BIIB or that he would have turned down a reasonable offer. If the study had been successful and BIIB had made an offer that Missling would not take, Biogen would have bought the company at a substantial premium to the stock price at the time. Also, I can’t imagine Anavex would have entered into the MTA without at least having an agreement in principle with Biogen on the terms of a collaboration if the remyelination study proved successful. I think the most likely result was that Biogen felt the study results did not warrant further investigation and the MTA ended.